It is literally the front line therapy option for cholangiocarcinoma - gemcitabine + cisplatin. Currently, chemotherapy and chemotherapy containing regimens are CF33s number one competitior.
You didn't even know HER-Vaxx was falling off a patent cliff, did you?
You strike me as an amateur who should spend more time listening than talking.
IMU Price at posting:
3.8¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)